News
Novo Nordisk, GoodRX, CVS
Digest more
GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click ...
Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results